Repaglinide Teva

Medicinal product

(Invented) name

Repaglinide Teva

Active substance (s)

Repaglinidas

Strength

2 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10BX02, Repaglinide

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2009-06-29

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tablet	1 vnt.
Repaglinidas	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
37039	50658	1050658	lizdinė plokštelė	N30		Receptinis	EU/1/09/530/011	Netiekiama	-	-	No	-	-
37040	50659	1050659	lizdinė plokštelė	N90		Receptinis	EU/1/09/530/012	Netiekiama	-	-	No	-	-
37041	50660	1050660	lizdinė plokštelė	N120		Receptinis	EU/1/09/530/013	Netiekiama	-	-	No	-	-
37042	50661	1050661	lizdinė plokštelė	N270		Receptinis	EU/1/09/530/014	Netiekiama	-	-	No	-	-
37043	50662	1050662	lizdinė plokštelė	N360		Receptinis	EU/1/09/530/015	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2009-06-29	Registruotas